The board has rejected both of Anne Wojcicki’s buyout proposals to save the struggling genetics company
Seven of eight members of 23andMe’s board have resigned in yet another blow to the struggling genetics company. The CEO is now the only remaining member.
The independent directors of the genetic testing firm said in a letter posted Tuesday that they were quitting the company’s board after not receiving a satisfactory buyout offer from the CEO, Anne Wojcicki.
More Stories
I became absorbed in strangers’ fertility journeys online
Microsoft unveils chip it says could bring quantum computing within years
Ex-US security officials urge funding for science research to keep up with China